Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PXL770 in NAFLD
NCT03763877Phase 2Completed
- Sponsor
- Poxel SA
- Start
- Mar 2019
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PXL770 in non-alcoholic fatty liver disease (NAFLD), sponsored by Poxel SA. Started Mar 2019; status: completed.
02
Drugs
PXL770
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT03763877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03763877.